GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
0 hedge funds and large institutions have $0 invested in Genomic Health, Inc. in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 219 closing their positions.
Holders
–
Holders Change
-221
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
219
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$0 |
| 2 |
2
BlackRock
New York
|
$0 |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$0 |
| 4 |
4
Renaissance Technologies
New York
|
$0 |
| 5 |
5
State Street
Boston,
Massachusetts
|
$0 |
